Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)

B. Abderrahman; P. Y. Maximov; R. F. Curpan; J. S. Hanspal; P. Fan; R. Xiong; D. A. Tonetti; G. R.J. Thatcher; V. C. Jordan

doi:10.1124/molpharm.120.000054err

Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)

B. Abderrahman, P. Y. Maximov, R. F. Curpan, J. S. Hanspal, P. Fan, R. Xiong, D. A. Tonetti, G. R.J. Thatcher, V. C. Jordan

Pharmacology and Toxicology

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Abstract

The above article [Abderrahman B, Maximov PY, Curpan RF, Hanspal JS, Fan P, Xiong R, Tonetti DA, Thatcher GRJ, and Jordan VC (2020) Mol Pharmacol, 98: 364-381; DOI: Https:// doi.org/10.1124/molpharm.120.000054] was incorrectly identified as an emerging concepts article when the copyedited and formatted version went online. It is a regular article. The HTML and PDF versions have been corrected. The compositor apologizes for any inconvenience caused by this error.

Original language	English (US)
Pages (from-to)	528
Number of pages	1
Journal	Molecular pharmacology
Volume	98
Issue number	4
DOIs	https://doi.org/10.1124/molpharm.120.000054err
State	Published - Oct 2020

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

Access to Document

10.1124/molpharm.120.000054err

Fingerprint

Dive into the research topics of 'Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)'. Together they form a unique fingerprint.

Cite this

Abderrahman, B., Maximov, P. Y., Curpan, R. F., Hanspal, J. S., Fan, P., Xiong, R., Tonetti, D. A., Thatcher, G. R. J., & Jordan, V. C. (2020). Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054). Molecular pharmacology, 98(4), 528. https://doi.org/10.1124/molpharm.120.000054err

Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054). / Abderrahman, B.; Maximov, P. Y.; Curpan, R. F. et al.
In: Molecular pharmacology, Vol. 98, No. 4, 10.2020, p. 528.

Research output: Contribution to journal › Comment/debate › peer-review

Abderrahman, B, Maximov, PY, Curpan, RF, Hanspal, JS, Fan, P, Xiong, R, Tonetti, DA, Thatcher, GRJ & Jordan, VC 2020, 'Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)', Molecular pharmacology, vol. 98, no. 4, pp. 528. https://doi.org/10.1124/molpharm.120.000054err

Abderrahman B, Maximov PY, Curpan RF, Hanspal JS, Fan P, Xiong R et al. Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054). Molecular pharmacology. 2020 Oct;98(4):528. doi: 10.1124/molpharm.120.000054err

@article{822cabe49de14ca49aa1109eaacb0d7c,

title = "Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)",

abstract = "The above article [Abderrahman B, Maximov PY, Curpan RF, Hanspal JS, Fan P, Xiong R, Tonetti DA, Thatcher GRJ, and Jordan VC (2020) Mol Pharmacol, 98: 364-381; DOI: Https:// doi.org/10.1124/molpharm.120.000054] was incorrectly identified as an emerging concepts article when the copyedited and formatted version went online. It is a regular article. The HTML and PDF versions have been corrected. The compositor apologizes for any inconvenience caused by this error.",

author = "B. Abderrahman and Maximov, {P. Y.} and Curpan, {R. F.} and Hanspal, {J. S.} and P. Fan and R. Xiong and Tonetti, {D. A.} and Thatcher, {G. R.J.} and Jordan, {V. C.}",

year = "2020",

month = oct,

doi = "10.1124/molpharm.120.000054err",

language = "English (US)",

volume = "98",

pages = "528",

journal = "Molecular pharmacology",

issn = "0026-895X",

publisher = "American Society for Pharmacology and Experimental Therapy (ASPET)",

number = "4",

}

TY - JOUR

T1 - Erratum

T2 - Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)

AU - Abderrahman, B.

AU - Maximov, P. Y.

AU - Curpan, R. F.

AU - Hanspal, J. S.

AU - Fan, P.

AU - Xiong, R.

AU - Tonetti, D. A.

AU - Thatcher, G. R.J.

AU - Jordan, V. C.

PY - 2020/10

Y1 - 2020/10

N2 - The above article [Abderrahman B, Maximov PY, Curpan RF, Hanspal JS, Fan P, Xiong R, Tonetti DA, Thatcher GRJ, and Jordan VC (2020) Mol Pharmacol, 98: 364-381; DOI: Https:// doi.org/10.1124/molpharm.120.000054] was incorrectly identified as an emerging concepts article when the copyedited and formatted version went online. It is a regular article. The HTML and PDF versions have been corrected. The compositor apologizes for any inconvenience caused by this error.

AB - The above article [Abderrahman B, Maximov PY, Curpan RF, Hanspal JS, Fan P, Xiong R, Tonetti DA, Thatcher GRJ, and Jordan VC (2020) Mol Pharmacol, 98: 364-381; DOI: Https:// doi.org/10.1124/molpharm.120.000054] was incorrectly identified as an emerging concepts article when the copyedited and formatted version went online. It is a regular article. The HTML and PDF versions have been corrected. The compositor apologizes for any inconvenience caused by this error.

UR - http://www.scopus.com/inward/record.url?scp=85091544100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091544100&partnerID=8YFLogxK

U2 - 10.1124/molpharm.120.000054err

DO - 10.1124/molpharm.120.000054err

M3 - Comment/debate

C2 - 32967933

AN - SCOPUS:85091544100

SN - 0026-895X

VL - 98

SP - 528

JO - Molecular pharmacology

JF - Molecular pharmacology

IS - 4

ER -

Erratum: Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer (Molecular Pharmacology (2020) 98 (364-381) DOI: 10.1124/molpharm.120.000054)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this